Browsing by Author Dore, GJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2013CCR5-Delta32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infectionAhlenstiel, Golo; Booth, David; George, Jacob; O'Connor, Kate; Stewart, Graeme; Suppiah, Vijayaprakash; Abate, Maria; Armstrong, Nicola; Bassendine, Maragaret; Berg, T; Dore, GJ; et al, Various; Irving, William; Mueller, Tobias; Nattermann, J; Powell, E; Riordan, Stephen; Spengler, Ulrich; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteCCR5-Delta32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection, Genes and Immunity, vol.14, 5, 2013,pp 286-290
2015Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 InfectionGeorge, Jacob; Strasser, Simone; Dore, GJ; et al, Various; Hezode, Christophe; Lawitz, Eric; Ramji, Alnoor; Shafran, Stephen; Taliani, Gloria; Tatum, Harvey; Tran, Albert; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: MedicineDaclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection, Gastroenterology, vol.148, 2, 2015,pp 355-366